Lilly recruits Avidity Biosciences to develop antibody-oligonucleotide conjugates

Tuesday, May 28, 2019 - 20:07 in Biology & Nature

Avidity's technology will help the duo get RNA therapies to immune cells

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net